Nakasu, Y., Mitsuya, K., Hayashi, N., Okamura, I., Mori, K., Enami, T., . . . Ikeda, T. (2016). Response-adapted treatment with upfront high-dose chemotherapy followed by autologous stem-cell transplantation rescue or consolidation phase high-dose methotrexate for primary central nervous system lymphoma: A long-term mono-center study. Springerplus.
Citação norma ChicagoNakasu, Yoko, Koichi Mitsuya, Nakamasa Hayashi, Ikue Okamura, Keita Mori, Terukazu Enami, Raine Tatara, Satoshi Nakasu, and Takashi Ikeda. "Response-adapted Treatment With Upfront High-dose Chemotherapy Followed By Autologous Stem-cell Transplantation Rescue or Consolidation Phase High-dose Methotrexate for Primary Central Nervous System Lymphoma: A Long-term Mono-center Study." Springerplus 2016.
MLA citiranjeNakasu, Yoko, et al. "Response-adapted Treatment With Upfront High-dose Chemotherapy Followed By Autologous Stem-cell Transplantation Rescue or Consolidation Phase High-dose Methotrexate for Primary Central Nervous System Lymphoma: A Long-term Mono-center Study." Springerplus 2016.